Chrispin Kambili is an Infectious Disease physician affiliated with Johnson & Johnson. OpenAlex indexes 36 publications with 310 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
34-33 Junction Blvd
Corona Chest Center Fl2
Jackson Heights, NY 113723828
Telephone
718-396-5134Provider last certified this registry record 20 Mar 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20251 payment
- Janssen Research & Development, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2010–2011 per NIH RePORTER. The latest:
- TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
New York City Health/mental Hygiene
FY2011$8,599,199U52PS200462 - TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
New York City Health/mental Hygiene
FY2010$8,993,816U52PS200462
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
The International Journal of Tuberculosis and Lung Disease
2022 - Bedaquiline for multidrug-resistant TB in paediatric patients
The International Journal of Tuberculosis and Lung Disease
2021 - The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa
Expert Review of Anti-infective Therapy
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Wayne Drevets, MD
Johnson & Johnson
Matthew Breyer, MD
Johnson & Johnson
Deepu Madduri, MD
Johnson & Johnson
Elliot Barnathan, MD
Johnson & Johnson
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”